Massive blood loss in surgery for renal cell carcinoma associated with inferior vena cava tumor thrombus: Observational study

Cover Page

Cite item

Full Text

Abstract

Background. An effective treatment for renal cell carcinoma complicated by tumor thrombus (TT) is nephrectomy with thrombectomy (NETE) from the inferior vena cava (IVC), which is associated with massive blood loss, high morbidity and mortality. The study aims to evaluate the infusion-transfusion protocol (ITP) for NETE from the IVC without extracorporeal circulation.

Materials and methods. The observational single-center study included 682 patients who were operated for NETE for renal cell carcinoma with TT. Patients were divided into 3 groups depending on the level of TT according to the Mayo classification. The InfraHepatic (InH) group included patients with TT levels I and II, the RetroHepatic (RH) group included patients with TT level III, and the SupraDiaphragmatic (SD) group included patients with TT level IV. Own concept of moderately advanced infusion in the amount of 130–140% of all losses were introduced. Qualitative and quantitative composition of ITP, frequency of use of sympathomimetics, complications and mortality were assessed.

Results. The rate of massive blood loss was 46.9% in the InH group, 74.7% in the RH group, and 86.3% in the SD group. ITP was characterized a significant increase in the absolute values of all infusion media, a decrease the proportion of crystalloids and colloids, an increase the proportion fresh frozen plasma, donated erythrocytes, and proportion of auto-erythrocytes between groups. The frequency of using intraoperative cell salvage in the InH group was 39.6%, in the RH – 67.7%, in the SD – 90.7%. The greatest hemodynamic shifts were recorded in the SD group. The frequency of postoperative complications was 24.3%, and hospital mortality was 7% with accordance to the ITP, adequate hemodynamic and laboratory monitoring in NETE. Low mortality due to hemorrhagic shock in our study (0.15%) emphasizes the effectiveness of the presented ITP.

Conclusion. The obtained data demonstrate the results of NETE as comparable with those presented in the available literature.

About the authors

Pavel I. Feoktistov

Blokhin National Medical Research Center of Oncology

Author for correspondence.
Email: festeraddamzz@mail.ru
ORCID iD: 0000-0001-6024-5817

Cand. Sci. (Med.)

Russian Federation, Moscow

Alexandr R. Shin

Blokhin National Medical Research Center of Oncology

Email: festeraddamzz@mail.ru
ORCID iD: 0000-0002-3595-3472

Cand. Sci. (Med.)

Russian Federation, Moscow

Alexey O. Prikhodchenko

EAFO Educational and Research Center “Eurasian Oncology Program”; Expert Council “Health Direct”

Email: Evpatii2004@mail.ru
ORCID iD: 0000-0002-4770-0034

Cand. Sci. (Med.)

Russian Federation, Moscow; Moscow

Evgeniya N. Feoktistova

Blokhin National Medical Research Center of Oncology

Email: festeraddamzz@mail.ru
ORCID iD: 0000-0002-5703-141X

anesthesiologist-intensivist

Russian Federation, Moscow

Pavel V. Vyatkin

Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology

Email: festeraddamzz@mail.ru
ORCID iD: 0000-0003-2976-2562

anesthesiologist-intensivist

Russian Federation, Moscow

References


Copyright (c) 2022 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies